OLFM4 is also linked to lymph node metastasis in GC patients, and its depletion inhibits GC cell tumorigenicity in vitro and in vivo by enhancing caspase-3-dependent apoptosis [80,81,82]. Here, OLFM4 is linked to gastric cancer.